🐜
|
Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue
13 auth.
Liang Chen,
Youhuai Li,
Yebo Fu,
Jin Peng,
Meng-Hsuan Mo,
M. Stamatakos,
C. Teal,
R. Brem,
A. Stojadinovic,
M. Grinkemeyer,
...
T. McCaffrey,
Y. Man,
S. Fu
|
6 |
2013 |
6 🐜
|
🐢
|
Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
7 auth.
T. Tang,
Y. Cheng,
Qi She,
Yaru Jiang,
Yuanyuan Chen,
Wenqiang Yang,
...
Youhuai Li
|
6 |
2018 |
6 🐢
|
🦁
|
mRNA vaccine in cancer therapy: Current advance and future outlook
11 auth.
Youhuai Li,
Mina Wang,
Xueqiang Peng,
Yingying Yang,
Qishuang Chen,
Jiaxing Liu,
...
Qi She,
Jichao Tan,
Chuyuan Lou,
Zehuan Liao,
Xuexin Li
|
5 |
2023 |
5 🦁
|
🐢
|
A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis
Qi She,
Yuan Chen,
Hong Liu,
Jichao Tan,
Youhuai Li
|
2 |
2022 |
2 🐢
|
🐜
|
Anlotinib plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: A prospective, single-arm, single-center, phase II clinical study.
15 auth.
Xi Chen,
Shuqun Zhang,
Xuexin Li,
Yinbin Zhang,
Youhuai Li,
Huafeng Kang,
Guan Hai-tao,
Qi She,
Xiao-bin Ma,
Y. Diao,
...
Di Liu,
W. Min,
Mengjie Liu,
Fei Wu,
Cong Feng
|
0 |
2021 |
0 🐜
|